会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Pleural fluid localization device and method of using
    • 胸膜液定位装置及使用方法
    • US20050277827A1
    • 2005-12-15
    • US10864762
    • 2004-06-09
    • Alexandre Carvalho
    • Alexandre Carvalho
    • A61B5/05A61B19/00
    • A61B90/39A61B2090/376A61B2090/3937
    • A novel pleural fluid localization device and method of using is disclosed. The device includes a marker, having a top side, a bottom side adapted to be affixed to the body of a patient, a top edge, a first side edge, a second side edge, and a bottom edge; and a first plurality of markings on the marker to guide a clinician in localizing an area on the body a patient to perform a procedure on the patient. The method includes placing the marker on the body of the patient; imaging the patient; reading the location on the plurality of markings on the marker to localize the procedure on the patient; and performing the procedure on the patient at the location read on the plurality of markings on the marker during the step of reading the location on the plurality of markings on the marker to localize the procedure on the patient.
    • 公开了一种新颖的胸膜液定位装置和使用方法。 该装置包括标记物,其具有顶侧,适于固定到患者身体的底侧,顶部边缘,第一侧边缘,第二侧边缘和底部边缘; 以及在所述标记上的第一多个标记,以引导临床医生将身体上的区域定位在患者身上以对患者执行手术。 该方法包括将标记放置在患者的身体上; 成像患者; 读取标记上的多个标记上的位置以定位患者的程序; 以及在读取标记上的多个标记上的位置的步骤中对在患者上的多个标记上读取的位置处的患者执行该过程以定位患者的程序。
    • 3. 发明申请
    • Compositions of allosteric hemoglobin modifiers and methods of making the same
    • 变构血红蛋白修饰剂的组成及其制备方法
    • US20050239893A1
    • 2005-10-27
    • US11112389
    • 2005-04-22
    • Al QuickAntonio SantosAlexandre CarvalhoDouglas JohnsonJeffrey EtterChristopher Murray
    • Al QuickAntonio SantosAlexandre CarvalhoDouglas JohnsonJeffrey EtterChristopher Murray
    • A61K31/195
    • A61K31/195
    • The present invention provides novel compositions of allosteric hemoglobin modifiers which are substantially free of impurities, specifically polymeric impurities. In one embodiment, the novel compositions contain an allosteric hemoglobin modifier compound and less than 100 ppm of the polymeric impurities generated during the preparation of this compound. Included in the present invention are novel methods for preparing allosteric hemoglobin modifiers that are substantially free of polymeric impurities. Also included in the present invention are improved methods for the purification of the product formed by the method of this invention. The novel methods of purification comprise extracting the crude composition with a water immiscible or partially immiscible solvent such as methylisobutyl ketone (MIBK) to lower amounts of impurities, specifically polymeric impurities. Also included are methods to reduce impurities by recrystallization of the crude synthesized product, followed by filtration of the recrystallized product. The present invention also includes the products made by the processes of the invention and methods for analyzing compositions comprised of these products.
    • 本发明提供基本上不含杂质,特别是聚合物杂质的变构血红蛋白改性剂的新型组合物。 在一个实施方案中,新型组合物含有变构血红蛋白改性剂化合物,并且在制备该化合物期间产生小于100ppm的聚合物杂质。 本发明包括制备基本上不含聚合物杂质的变构型血红蛋白改性剂的新方法。 本发明还包括用于纯化通过本发明方法形成的产品的改进方法。 新的纯化方法包括用与水不混溶或部分不混溶的溶剂如甲基异丁基酮(MIBK)萃取粗组合物以降低杂质量,特别是聚合物杂质。 还包括通过粗合成产物的重结晶减少杂质的方法,然后过滤重结晶产物。 本发明还包括通过本发明的方法制备的产品和用于分析由这些产品组成的组合物的方法。